Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients

PHASE3CompletedINTERVENTIONAL

Enrollment

212

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

January 31, 2006

Conditions

Pediatric Kidney Transplantation

Interventions

DRUG

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)

DRUG

MMF, cyclosporine, steroids